Skip to main content

Table 4 Adjusted relative risks for factors associated with acceptability of PreP by mode and frequency of administration

From: Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU): a cross-sectional survey

Characteristic

Daily PrEP

RR (95% CI)

p-value

Monthly Injection = (RR 95% CI)

p-value

Every 2 month injection (RR 95% CI)

p-value

Any Prep RR (95% CI)

p-value

Male Gender

0.74 (0.37–1.48)

0.40

0.67 (0.34–1.33)

0.25

0.62 (0.31–1.21)

0.16

0.78 (0.38–1.60)

0.51

Age (per 1 year increase)

0.98 (0.79–1.23)

0.90

1.14 (0.91–1.42)

0.25

1.10 (0.88–1.37)

0.40

1.05 (0.83–1.33)

0.70

Freshman

1.24 (0.60–2.57)

0.55

1.72 (0.84–3.51)

0.13

1.80 (0.89–3.69)

0.10

1.33 (0.62–2.86)

0.45

Sophomore

1.03 (0.51–2.05)

0.92

0.68 (0.35–1.35)

0.27

0.82 (0.41–1.60)

0.56

0.92 (0.45–1.88)

0.82

Junior

0.83 (0.40–1.73)

0.63

0.76 (0.37–1.55)

0.45

0.79 (0.38–1.60)

0.51

0.69 (0.32–1.49)

0.35

Senior or higher

1.60 (0.59–4.38)

0.35

1.74 (0.65–4.66)

0.26

1.43 (0.53–3.83)

0.48

2.32 (0.70–7.67)

0.17

Non-Heterosexual Orientation

2.27 (0.76–6.81)

0.14

1.28 (0.48–3.37)

0.62

1.22 (0.45–3.29)

0.69

2.51 (0.69–9.11)

0.16

Perceived Risk

2.66 (1.31–5.42)

0.007

1.80 (0.93–3.44)

0.08

1.23 (0.64–2.38)

0.52

1.60 (0.77–3.32)

0.21